Assessing comorbidity in older adults using prescription claims data

Journal of Pharmaceutical Health Services Research

Volumn 1, Issue 4, 2010, Pages 157-165

  Dubois, Marie France ^a,b   Dubuc, Nicole ^a,b   Kröger, Edeltraut ^c   Girard, Ronald ^d   Hébert, Réjean ^b,e  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY INSTITUTE OF GERIATRICS OF SHERBROOKE   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d Clinique Médicale des Cantons   (Canada)

^e UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Comorbidity; Disability; Older adults; Prescription claims databases

Indexed keywords

AGED; ARTICLE; CHRONIC DISEASE SCORE FOR DISABILITY IN OLDER ADULTS; COMORBIDITY; CONSTRUCT VALIDITY; CONTROLLED STUDY; DATA BASE; DISABILITY; FEMALE; FRAIL ELDERLY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; PHARMACOEPIDEMIOLOGY; PHARMACY; PREDICTIVE VALIDITY; PRESCRIPTION; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 79953765273     PISSN: 17598885     EISSN: 17598893     Source Type: Journal    
DOI: 10.1111/j.1759-8893.2010.00030.x     Document Type: Article

References (39)

1. de Groot V et al. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 2003; 56: 221-229.
2. Lash TL et al. Methodology, design, and analytic techniques to address measurement of comorbid disease. J Gerontol A Biol Sci Med Sci 2007; 62: 281-285.
3. Katz JN et al. Can comorbidity be measured by questionnaire rather than medical record review? Med Care 1996; 34: 73-84.
4. Iezzoni LI. Assessing quality using administrative data. Ann Intern Med 1997; 127: 666-674.
5. Sales AE et al. Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population. Med Care 2003; 41: 753-760.
6. Von Korff M et al. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992; 45: 197-203.
7. Johnson RE et al. Replicating the Chronic Disease Score (CDS) from automated pharmacy data. J Clin Epidemiol 1994; 47: 1191-1199.
8. Clark DO et al. A chronic disease score with empirically derived weights. Med Care 1995; 33: 783-795.
9. Maio V et al. Using pharmacy data to identify those with chronic conditions in Emilia Romagna, Italy. J Health Serv Res Policy 2005; 10: 232-238.
10. McGregor JC et al. Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections. J Clin Epidemiol 2006; 59: 1266-1273.
11. Gilmer T et al. The Medicaid Rx model: pharmacy-based risk adjustment for public programs. Med Care 2001; 39: 1188-1202.
12. Fishman PA et al. Risk adjustment using automated ambulatory pharmacy data: the RxRisk model. Med Care 2003; 41: 84-99.
13. Sloan KL et al. Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care 2003; 41: 761-774.
14. Johnson ML et al. Adapting the Rx-Risk-V for mortality prediction in outpatient populations. Med Care 2006; 44: 793-797.
15. Malone DC et al. Development of a chronic disease indicator score using a Veterans Affairs Medical Center medication database. J Clin Epidemiol 1999; 52: 551-557.
16. Schneeweiss S et al. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res 2003; 38: 1103-1120.
17. Di Bari M et al. Predictive validity of measures of comorbidity in older community dwellers: the Insufficienza Cardiaca negli Anziani Residenti a Dicomano Study. J Am Geriatr Soc 2006; 54: 210-216.
18. Farley JF et al. A comparison of comorbidity measurements to predict healthcare expenditures. Am J Epidemiol 2006; 12: 110- 117.
19. Perkins AJ et al. Common comorbidity scales were similar in their ability to predict health care costs and mortality. J Clin Epidemiol 2004; 57: 1040-1048.
20. Hébert R et al. The effectiveness of the PRISMA integrated service delivery network: preliminary report on methods and baseline data. Int J Integr Care 2008; 8: 1-15.
21. Hébert R et al. Predictive validity of a postal questionnaire for screening community-dwelling elderly individuals at risk of functional decline. Age Ageing 1996; 25: 159-167.
22. Kleinbaum DG et al. Applied Regression Analysis and Other Multivariable Methods, 2nd edn. Belmont, CA: PWS-Kent Publishing Company, 1988.
23. Hébert R et al. The Functional Autonomy Measurement System (SMAF): description and validation of an instrument for the measurement of handicaps. Age Ageing 1988; 17: 293-302.
24. Desrosiers J et al. Reliability of the revised Functional Autonomy Measurement System (SMAF) for epidemiological research. Age Ageing 1995; 24: 402-406.
25. Tamblyn R et al. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995; 48: 999-1009.
26. Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000; 29: 891-898.
27. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 420-428.
28. Dubois M-F et al. Assisted self-report of health-services use showed excellent reliability in a longitudinal study of older adults. J Clin Epidemiol 2007; 60: 1040-1045.
29. Folstein MF et al. 'Minimental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
30. Hébert R et al. Setting the minimal metrically detectable change on disability rating scales. Arch Phys Med Rehabil 1997; 78: 1305-1308.
31. Guralnik JM. Assessing the impact of comorbidity in the older population. Ann Epidemiol 1996; 6: 376-380.
32. World Health Organization. International Classification of Functioning, Disability and Health: ICF. Geneva: World Health Organization, 2001.
33. Groll DL et al. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 2005; 58: 595-602.
34. Zhao Y et al. Measuring population health risks using inpatient diagnoses and outpatient pharmacy data. Health Serv Res 2001; 36: 180-193.
35. Parker JP et al. Can pharmacy data improve prediction of hospital outcomes? Comparisons with a diagnosis-based comorbidity measure. Med Care 2003; 41: 407-419.
36. Shepherd J et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002; 360: 1623-1630.
37. McCormick WC et al. The effect of diagnosing Alzheimer's disease on frequency of physician visits: a case-control study. J Gen Intern Med 1995; 10: 187-193.
38. Schneeweiss S et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001; 154: 854-864.
39. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index. Oslo: Norwegian Institute of Public Health, 2010. http://www.whocc.no/atc_ddd_index/ (accessed 22 June 2010).